These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms. Yang Y; Yang L; Li Y Hum Pathol; 2018 Nov; 81():192-200. PubMed ID: 30420046 [TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361 [TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Parikh AA; Fan F; Liu WB; Ahmad SA; Stoeltzing O; Reinmuth N; Bielenberg D; Bucana CD; Klagsbrun M; Ellis LM Am J Pathol; 2004 Jun; 164(6):2139-51. PubMed ID: 15161648 [TBL] [Abstract][Full Text] [Related]
16. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors. Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256 [TBL] [Abstract][Full Text] [Related]
17. GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses. Zanini S; Giovinazzo F; Alaimo D; Lawrence B; Pfragner R; Bassi C; Modlin I; Kidd M Cell Signal; 2015 May; 27(5):899-907. PubMed ID: 25701539 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619 [TBL] [Abstract][Full Text] [Related]
19. Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT. Svejda B; Kidd M; Kazberouk A; Lawrence B; Pfragner R; Modlin IM Cancer; 2011 Sep; 117(18):4141-54. PubMed ID: 21387274 [TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? Mohamed A; Romano D; Saveanu A; Roche C; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Garcia S; Ferone D; Florio T; Moutardier V; Poizat F; Barlier A; Gerard C Oncotarget; 2017 Jun; 8(25):41044-41063. PubMed ID: 28454119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]